<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39460652</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2053-1095</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Veterinary medicine and science</Title><ISOAbbreviation>Vet Med Sci</ISOAbbreviation></Journal><ArticleTitle>Stability of Sodium Pentobarbital 5w/v% Aqueous Solution During Short-Term Chilled and Ambient-Temperature Storage.</ArticleTitle><Pagination><StartPage>e70066</StartPage><MedlinePgn>e70066</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70066</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/vms3.70066</ELocationID><Abstract><AbstractText>The COVID-19 pandemic made it difficult to obtain pharmaceutical-grade injectable anaesthetics used in animal experiments in Japan. To address this problem, it is worth the effort to evaluate whether the use of non-pharmaceutical-grade sodium pentobarbital (PBNa) water solution can be an alternative one from the perspective of stability, physicochemical properties, bioavailability and so on. In this article, as a first step, we examined the stability of PBNa 5w/v% aqueous solution (PBNa 5% AS). PBNa 5% AS sample was prepared simply by dissolving non-pharmaceutical-grade PBNa into water and was stored at 25°C and 5°C for 15 days. Visual appearance, pH, osmolality and assay (contents of PBNa and related substances) were tested. The stability test results indicated that there was no profound change in these test items of the PBNa 5% AS under either storage condition, suggesting that the formulation was sufficiently stable in such a short term. The only observable change was an increase of an impurity under 25°C storage; however, it was at a negligible level. Moreover, as the pH of the formulation remained &lt;10.0 throughout the storage period in both conditions, the irritant level of the pH is considered to be acceptable. Therefore, from the viewpoint of the stability and physicochemical properties, PBNa 5% AS can be an alternative injectable anaesthetic when access to pharmaceutical-grade anaesthetics is limited, as long as used in short-term from its preparation.</AbstractText><CopyrightInformation>© 2024 The Author(s). Veterinary Medicine and Science published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dohi</LastName><ForeName>Masakazu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Central Research Laboratories, Research &amp; Development Division, Senju Pharmaceutical Co. Ltd., Kobe, Hyogo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ueda</LastName><ForeName>Kayoko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Central Research Laboratories, Research &amp; Development Division, Senju Pharmaceutical Co. Ltd., Kobe, Hyogo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamagiwa</LastName><ForeName>Yoshinori</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-9552-0217</Identifier><AffiliationInfo><Affiliation>Central Research Laboratories, Research &amp; Development Division, Senju Pharmaceutical Co. Ltd., Kobe, Hyogo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamashita</LastName><ForeName>Atsuko</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Central Research Laboratories, Research &amp; Development Division, Senju Pharmaceutical Co. Ltd., Kobe, Hyogo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakamoto</LastName><ForeName>Yuji</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Central Research Laboratories, Research &amp; Development Division, Senju Pharmaceutical Co. Ltd., Kobe, Hyogo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Vet Med Sci</MedlineTA><NlmUniqueID>101678837</NlmUniqueID><ISSNLinking>2053-1095</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>I4744080IR</RegistryNumber><NameOfSubstance UI="D010424">Pentobarbital</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D010424" MajorTopicYN="Y">Pentobarbital</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004355" MajorTopicYN="Y">Drug Stability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004356" MajorTopicYN="Y">Drug Storage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013696" MajorTopicYN="N">Temperature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003080" MajorTopicYN="N">Cold Temperature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anaesthetics agents</Keyword><Keyword MajorTopicYN="N">chemical analysis</Keyword><Keyword MajorTopicYN="N">euthanasia</Keyword><Keyword MajorTopicYN="N">pentobarbital</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>7</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39460652</ArticleId><ArticleId IdType="pmc">PMC11512436</ArticleId><ArticleId IdType="doi">10.1002/vms3.70066</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>

Brynjelsen, S. E.
, and Pati B.. 2016. Stable Pentobarbital Formulation. US 9,517,269 B1. U.S. Patent. https://patentimages.storage.googleapis.com/ad/7f/46/0f062ef1069e71/US9517269.pdf.</Citation></Reference><Reference><Citation>Gad, S. C. , Spainhour C. B., Shoemake C., et al. 2016. “Tolerable Levels of Nonclinical Vehicles and Formulations Used in Studies by Multiple Routes in Multiple Species With Notes on Methods to Improve Utility.” International Journal of Toxicology 35: 95–178. 10.1177/1091581815622442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1091581815622442</ArticleId><ArticleId IdType="pubmed">26755718</ArticleId></ArticleIdList></Reference><Reference><Citation>
Indiana University alternatively
. [Internet]. 2014. Use of Non‐Pharmaceutical Grade Chemicals and Compounds in Laboratory Animals. Indianapolis: Indiana University;  [Cited 01 October 2024]. https://research.iu.edu/doc/compliance/animal‐care/iupui/iupui‐iacuc‐use‐of‐non‐pharmaceutical‐grade‐chemicals‐compounds.pdf.</Citation></Reference><Reference><Citation>Institute for Laboratory Animal Research . 2011. Guide for the Care and Use of Laboratory Animals. Washington (DC): National Academies Press.</Citation></Reference><Reference><Citation>Laferriere, C. A. , and Pang D. S.. 2020. “Review of Intraperitoneal Injection of Sodium Pentobarbital as a Method of Euthanasia in Laboratory Rodents.” Journal of the American Association for Laboratory Animal Science 59: 254–263. 10.30802/AALAS-JAALAS-19-000081.</Citation><ArticleIdList><ArticleId IdType="doi">10.30802/AALAS-JAALAS-19-000081</ArticleId><ArticleId IdType="pmc">PMC7338870</ArticleId><ArticleId IdType="pubmed">32156325</ArticleId></ArticleIdList></Reference><Reference><Citation>Morey, J. A. , and Elrod L. Jr. 1997. “Determination of Pentobarbital and Pentobarbital Sodium in Bulk Drug Substance and Dosage Forms by High‐Performance Liquid Chromatography.” Journal of Pharmaceutical and Biomedical Analysis 23: 4256–4265. 10.1016/S0731-7085(96)02045-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0731-7085(96)02045-6</ArticleId><ArticleId IdType="pubmed">9447559</ArticleId></ArticleIdList></Reference><Reference><Citation>Priest, S. M. , and Geisbuhler T. P.. 2015. “Injectable Sodium Pentobarbital: Stability at Room Temperature.” Journal of Pharmacological and Toxicological Methods 76: 38–42. 10.1016/j.vascn.2015.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vascn.2015.07.012</ArticleId><ArticleId IdType="pubmed">26234474</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi, D. , Gelbrich T., Kahlenberg V., and Griesser U. J.. 2012. “Supramolecular Constructs and Thermodynamic Stability of Four Polymorphs and a Co‐Crystal of Pentobarbital (Nembutal).” CrystEngComm 14: 2494–2506. 10.1039/c2ce06659a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c2ce06659a</ArticleId></ArticleIdList></Reference><Reference><Citation>
University of Illinois Urbana‐Champaign
. [Internet]. 2021. Use of Non‐Pharmaceutical Grade Compounds in Animals. Champaign: University of Illinois Urbana‐Champaign;  [Cited 16 January 2023]. https://animalcare.illinois.edu/policies/use‐non‐pharmaceutical‐grade‐compounds‐animals.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>